Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Life-history predicts past and present population connectivity in two sympatric sea stars.

Puritz JB, Keever CC, Addison JA, Barbosa SS, Byrne M, Hart MW, Grosberg RK, Toonen RJ.

Ecol Evol. 2017 Apr 23;7(11):3916-3930. doi: 10.1002/ece3.2938. eCollection 2017 Jun.

2.

Sperm Bindin Divergence under Sexual Selection and Concerted Evolution in Sea Stars.

PatiƱo S, Keever CC, Sunday JM, Popovic I, Byrne M, Hart MW.

Mol Biol Evol. 2016 Aug;33(8):1988-2001. doi: 10.1093/molbev/msw081. Epub 2016 May 3.

PMID:
27189549
3.

Shallow gene pools in the high intertidal: extreme loss of genetic diversity in viviparous sea stars (Parvulastra).

Keever CC, Puritz JB, Addison JA, Byrne M, Grosberg RK, Toonen RJ, Hart MW.

Biol Lett. 2013 Aug 7;9(5):20130551. doi: 10.1098/rsbl.2013.0551. Print 2013 Oct 23.

4.

Extraordinarily rapid life-history divergence between Cryptasterina sea star species.

Puritz JB, Keever CC, Addison JA, Byrne M, Hart MW, Grosberg RK, Toonen RJ.

Proc Biol Sci. 2012 Oct 7;279(1744):3914-22. Epub 2012 Jul 18.

5.

Divergence genetics analysis reveals historical population genetic processes leading to contrasting phylogeographic patterns in co-distributed species.

McGovern TM, Keever CC, Saski CA, Hart MW, Marko PB.

Mol Ecol. 2010 Nov;19(22):5043-60. doi: 10.1111/j.1365-294X.2010.04854.x. Epub 2010 Oct 12.

PMID:
21040048
6.

The 'Expansion-Contraction' model of Pleistocene biogeography: rocky shores suffer a sea change?

Marko PB, Hoffman JM, Emme SA, Mcgovern TM, Keever CC, Cox LN.

Mol Ecol. 2010 Jan;19(1):146-69.

PMID:
20092033
7.

Discordant distribution of populations and genetic variation in a sea star with high dispersal potential.

Keever CC, Sunday J, Puritz JB, Addison JA, Toonen RJ, Grosberg RK, Hart MW.

Evolution. 2009 Dec;63(12):3214-27. doi: 10.1111/j.1558-5646.2009.00801.x. Epub 2009 Aug 3.

PMID:
19663996
8.

Discovery and cross-amplification of microsatellite polymorphisms in asterinid sea stars.

Keever CC, Sunday J, Wood C, Byrne M, Hart MW.

Biol Bull. 2008 Oct;215(2):164-72.

PMID:
18840777
9.

Something for nothing? Reconstruction of ancestral character states in asterinid sea star development.

Keever CC, Hart MW.

Evol Dev. 2008 Jan-Feb;10(1):62-73. doi: 10.1111/j.1525-142X.2008.00214.x.

PMID:
18184358
10.
11.

Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy.

Ritch PS, Keever C, Schiller J, Rivkin S, Witt PL, Grossberg SE, Truitt RL, Burris H, von Hoff DD, Vaickus L, et al.

Ann N Y Acad Sci. 1995 Jul 21;762:359-60. No abstract available.

PMID:
7668536
12.

Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells.

Keever CA, Abu-Hajir M, Graf W, McFadden P, Prichard P, O'Brien J, Flomenberg N.

Bone Marrow Transplant. 1995 Mar;15(3):407-19.

PMID:
7599566
13.

Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients.

Baxter-Lowe LA, Keever C, Dinauer D, Daniels T, Johnson K, Camitta B, Drobyski W, Garbrecht F, Horowitz M, Pietryga D, et al.

Transplant Proc. 1995 Feb;27(1):1377-8. No abstract available.

PMID:
7878917
14.

Analysis of reconstituting T cell receptor repertoires in bone marrow transplant recipients.

Gorski J, Yassai M, Keever C, Flomenberg N.

Arch Immunol Ther Exp (Warsz). 1995;43(2):93-7.

PMID:
8744722
16.

HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.

Keever CA, Leong N, Cunningham I, Copelan EA, Avalos BR, Klein J, Kapoor N, Adams PW, Orosz CG, Tutschka PJ, et al.

Bone Marrow Transplant. 1994 Jul;14(1):137-45.

PMID:
7951101
17.

Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status.

Gorski J, Yassai M, Zhu X, Kissela B, Kissella B [corrected to Kissela B], Keever C, Flomenberg N.

J Immunol. 1994 May 15;152(10):5109-19.

PMID:
8176227
18.

Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.

Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F, et al.

Blood. 1994 Apr 1;83(7):1980-7.

PMID:
8142664
19.

Component processing and intraoperative autotransfusion during bone marrow harvest.

Cook-Craig A, Owen A, Reeder G, Drobyski W, Horowitz M, Brunner J, Flomenberg N, Keever C.

Prog Clin Biol Res. 1994;389:613-9. No abstract available.

PMID:
7700927
20.

Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose.

Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM, et al.

Blood. 1993 Oct 15;82(8):2310-8.

PMID:
8400284
21.

Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT.

Keever CA, Klein J, Leong N, Copelan EA, Avalos BR, Kapoor N, Cunningham I, Tutschka PJ.

Bone Marrow Transplant. 1993 Sep;12(3):289-95.

PMID:
8241989
22.

Characterization of cord blood lymphocyte subpopulations.

Keever CA.

J Hematother. 1993 Summer;2(2):203-6.

PMID:
7921975
23.

Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.

Gazzola MV, Collins NH, Tafuri A, Keever CA.

Exp Hematol. 1992 Feb;20(2):201-8.

PMID:
1371965
25.

Cord blood transplants: potential utility and potential limitations.

Flomenberg N, Keever CA.

Bone Marrow Transplant. 1992;10 Suppl 1:115-20. Review.

PMID:
1521082
26.

Effects of ex vivo treatment with methylprednisolone and vincristine on bone marrow lymphohematopoietic cells.

Kapoor N, Keever CA, Leong N, Beck EX.

Prog Clin Biol Res. 1992;377:49-56. No abstract available.

PMID:
1438443
27.

Characterization of the in vitro sensitivity of human lymphoid and hematopoietic progenitors to L-leucyl-L-leucine methyl ester.

Pecora AL, Bordignon C, Fumagalli L, Radziejewski C, Small TN, Pekle K, O'Reilly RJ, Keever CA.

Transplantation. 1991 Feb;51(2):524-31.

PMID:
1994549
28.

Mixed lymphocyte reactions in Macaca fascicularis.

Heise ER, Manning CH, McMahan MR, Keever CA.

J Med Primatol. 1991;20(2):67-74. No abstract available.

PMID:
1830905
29.

B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny.

Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N.

Blood. 1990 Oct 15;76(8):1647-56.

PMID:
1698484
30.

Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease.

Keever CA, Flomenberg N, Gazzola MV, Pekle K, Yang SY, Small TN, Collins NH, O'Reilly RJ.

Hum Immunol. 1990 Sep;29(1):42-55.

PMID:
2211189
31.

Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia.

Hauch M, Gazzola MV, Small T, Bordignon C, Barnett L, Cunningham I, Castro-Malaspinia H, O'Reilly RJ, Keever CA.

Blood. 1990 Jun 1;75(11):2250-62.

PMID:
2189508
32.

Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells.

DiSanto JP, Keever CA, Small TN, Nicols GL, O'Reilly RJ, Flomenberg N.

J Exp Med. 1990 May 1;171(5):1697-704.

33.

Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency.

Rosenkrantz K, Keever C, Bhimani K, Horvath A, Brochstein J, O'Reilly R, Dupont B, Flomenberg N.

J Immunol. 1990 Mar 1;144(5):1721-8.

PMID:
2307837
34.

NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.

Keever CA, Pekle K, Gazzola MV, Collins NH, Gillio A.

Cell Immunol. 1990 Mar;126(1):211-26.

PMID:
1689220
35.

Restriction fragment polymorphism of the cynomolgus monkey major histocompatibility complex.

Schepart BS, Buck DA, Manning CH, Keever CA, McMahan MR, Heise ER.

Exp Clin Immunogenet. 1990;7(2):109-22.

PMID:
1969744
36.

Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.

Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.

J Immunol. 1989 Nov 15;143(10):3241-9.

PMID:
2809200
37.

Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms.

Bordignon C, Keever CA, Small TN, Flomenberg N, Dupont B, O'Reilly RJ, Kernan NA.

Blood. 1989 Nov 1;74(6):2237-43.

PMID:
2529927
38.

Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.

Bordignon C, Yu SF, Smith CA, Hantzopoulos P, Ungers GE, Keever CA, O'Reilly RJ, Gilboa E.

Proc Natl Acad Sci U S A. 1989 Sep;86(17):6748-52.

39.

Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease.

Keever CA, Flomenberg N, Small T, Brochstein J, Collins N, Young-Yang S, Insel R, Dupont B, O'Reilly RJ.

Hum Immunol. 1989 Sep;26(1):27-38.

PMID:
2528525
40.

Characterization of B cells in severe combined immunodeficiency disease.

Small TN, Keever C, Collins N, Dupont B, O'Reilly RJ, Flomenberg N.

Hum Immunol. 1989 Jul;25(3):181-93.

PMID:
2670851
41.

Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.

Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora A, Gillio A, Kernan NA, O'Reilly RJ.

Blood. 1989 Apr;73(5):1340-50.

PMID:
2649174
42.

The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease.

O'Reilly RJ, Keever CA, Small TN, Brochstein J.

Immunodefic Rev. 1989;1(4):273-309. Review.

PMID:
2698644
43.

Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency.

Keever CA, Flomenberg N, Brochstein J, Sullivan M, Collins NH, Burns J, Dupont B, O'Reilly RJ.

Clin Immunol Immunopathol. 1988 Sep;48(3):261-76.

PMID:
3042210
44.

Radiosensitivity of NK lytic activities and NK-mediated hematopoietic colony inhibition: effect of activation with IL-2 and blocking of the T-200 molecule.

Keever CA, Benazzi E, Kernan NA, Welte K, O'Reilly RJ, Bordignon C.

Cell Immunol. 1988 Apr 15;113(1):143-57.

PMID:
3259165
45.

In vitro correlates of graft-host tolerance after HLA-matched and mismatched marrow transplants: suggestions from limiting dilution analysis.

Rosenkrantz K, Keever C, Kirsch J, Horvath A, Bhimani K, O'Reilly R, Dupont B, Flomenberg N.

Transplant Proc. 1987 Dec;19(6 Suppl 7):98-103. No abstract available.

PMID:
3321650
46.

HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.

O'Reilly RJ, Keever C, Kernan NA, Brochstein J, Collins N, Flomenberg N, Laver J, Emanuel D, Dupont B, Cunningham I, et al.

Transplant Proc. 1987 Dec;19(6 Suppl 7):55-60. No abstract available.

PMID:
3321647
47.

Effects of in vivo administration of human recombinant IL-2 to cynomolgus monkeys after autologous bone marrow transplantation.

Keever CA, Gillio AP, Levick J, Bonilla MA, O'Reilly RJ, Welte K.

Transplant Proc. 1987 Dec;19(6 Suppl 7):157-61. No abstract available.

PMID:
3321643
48.

Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.

Keever CA, Welte K, Small T, Levick J, Sullivan M, Hauch M, Evans RL, O'Reilly RJ.

Blood. 1987 Dec;70(6):1893-903.

PMID:
3118990
49.

Graft failures after T cell depleted marrow transplants for leukemia: clinical and in vitro characteristics.

Kernan NA, Bordignon C, Keever CA, Cunningham I, Castro-Malaspina H, Collins NH, Small TN, Brochstein J, Emanuel D, Laver J, et al.

Transplant Proc. 1987 Dec;19(6 Suppl 7):29-32. No abstract available.

PMID:
2962353
50.

Supplemental Content

Loading ...
Support Center